Icotinib, an EGFR-TKI, for the treatment of brain metastases in non-small cell lung cancer:a retrosp

来源 :肿瘤学与转化医学:英文版 | 被引量 : 0次 | 上传用户:ksxxccna
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective Treatment of brain metastases from non-small cell lung cancer(NSCLC) is a challenge because of the poor prognosis. Icotinib is a new type of oral epidermal growth factor receptor(EGFR) tyrosine kinase inhibitor(TKI) used in the treatment of adva
其他文献
Micro RNAs(miRNAs), approximately 21 to 23 nucleotides(nt) in length, belong to a set of small non-coding RNA molecules that were not thought to be functional u
Cells usually undergo a long journey of evolution during the progression from normal to precancerous cells and finally to full-fledged cancer cells. Multiple ge
Objective As there is currently no clear recommendation for third-line chemotherapy for small cell lung cancer(SCLC), its efficacy is unknown. To date, there ha
Objective We studied the efficacy of salvage hepatectomy for treating recurrent hepatic cancer after radiofrequency ablation(RFA). Methods A retrospective analy
Objective This study aimed to combine tumor abnormal protein(TAP) and high-sensitivity C-reactive protein(hs-CRP) level detection to diagnose endometrial cancer